These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1286940)

  • 21. Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex.
    Betts L; Xiang S; Short SA; Wolfenden R; Carter CW
    J Mol Biol; 1994 Jan; 235(2):635-56. PubMed ID: 8289286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
    Seebach D; Beck AK; Bierbaum DJ
    Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine mapping of the antigen-antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster.
    Liu Z; Song D; Kramer A; Martin AC; Dandekar T; Schneider-Mergener J; Bautz EK; Dübel S
    J Mol Recognit; 1999; 12(2):103-11. PubMed ID: 10398401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different fate of sibling cells upon inhibition of transcription in G1.
    Adolph S; Müller R
    Exp Cell Res; 1994 Feb; 210(2):349-52. PubMed ID: 8299729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical characterization of Trypanosoma brucei RNA polymerase II.
    Das A; Li H; Liu T; Bellofatto V
    Mol Biochem Parasitol; 2006 Dec; 150(2):201-10. PubMed ID: 16962183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships.
    Falch E; Brehm L; Mikkelsen I; Johansen TN; Skjaerbaek N; Nielsen B; Stensbøl TB; Ebert B; Krogsgaard-Larsen P
    J Med Chem; 1998 Jul; 41(14):2513-23. PubMed ID: 9651156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The RNA Pol II CTD phosphatase Fcp1 is essential for normal development in Drosophila melanogaster.
    Tombácz I; Schauer T; Juhász I; Komonyi O; Boros I
    Gene; 2009 Oct; 446(2):58-67. PubMed ID: 19632310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2,4-Dinitrophenylhydrazone formation at the aldehyde derived by periodate cleavage of alpha-amanitin.
    Morris PW; McSwine R
    Int J Pept Protein Res; 1983 Nov; 22(5):597-602. PubMed ID: 6317583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila.
    Andrulis ED; Werner J; Nazarian A; Erdjument-Bromage H; Tempst P; Lis JT
    Nature; 2002 Dec 19-26; 420(6917):837-41. PubMed ID: 12490954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
    Plonska-Ocypa K; Sicinski RR; Plum LA; Grzywacz P; Frelek J; Clagett-Dame M; DeLuca HF
    Bioorg Med Chem; 2009 Feb; 17(4):1747-63. PubMed ID: 19167893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.
    Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD
    J Med Chem; 1996 May; 39(11):2219-31. PubMed ID: 8667365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity study at positions 3 and 4 of human neuropeptide S.
    Camarda V; Trapella C; Calo' G; Guerrini R; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
    Bioorg Med Chem; 2008 Oct; 16(19):8841-5. PubMed ID: 18793857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of "
    Matinkhoo K; Pryyma A; Wong AAWL; Perrin DM
    Chem Commun (Camb); 2021 Sep; 57(75):9558-9561. PubMed ID: 34477193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fifty years of amanitin.
    Wieland T; Faulstich H
    Experientia; 1991 Dec; 47(11-12):1186-93. PubMed ID: 1765129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clustered alpha-amanitin resistance mutations in mouse.
    Bartolomei MS; Corden JL
    Mol Gen Genet; 1995 Mar; 246(6):778-82. PubMed ID: 7898449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of structural features involved in binding of alpha-amanitin to a monoclonal antibody.
    Baumann K; Münter K; Faulstich H
    Biochemistry; 1993 Apr; 32(15):4043-50. PubMed ID: 8471612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periodate oxidation products derived from methylated alpha-amanitin: evidence for distinct aldehydic and non-aldehydic forms.
    Mullersman JE; Bonetti SJ; Preston JF
    Int J Pept Protein Res; 1991 Nov; 38(5):409-16. PubMed ID: 1666394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis of transcription: alpha-amanitin-RNA polymerase II cocrystal at 2.8 A resolution.
    Bushnell DA; Cramer P; Kornberg RD
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1218-22. PubMed ID: 11805306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential inhibition of cultured cell types by alpha-amanitin-bovine serum albumin conjugates.
    Hencin RS; Preston JF
    Mol Pharmacol; 1979 Nov; 16(3):961-9. PubMed ID: 530265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.